Availability and quantity of antidotes in New Zealand
Schep, L.J.; Slaughter, R.J.
New Zealand Medical Journal 128(1411): 20-22
2015
ISSN/ISBN: 1175-8716 PMID: 25820499 Document Number: 679814
Document emailed within 1 workday
Related Documents
Fountain, J.S.; Sly, B.; Holt, A.; MacDonell, S. 2015: Availability of antidotes, antivenoms, and antitoxins in New Zealand hospital pharmacies New Zealand Medical Journal 128(1411): 23-33Jacobsen, P.; Kristensen, T.R.øn.; Jensen, K. 2004: Availability of antidotes in Denmark Ugeskrift for Laeger 166(47): 4257-4260
Daunderer, M. 1978: Therapy for poisonings--antidotes. 1. the ABC of poisoning treatment, antidotes (indications, dosage) Fortschritte der Medizin 96(25): 1313-1317
Moore, J.; Gale, J.; Dew, K.; Davie, G. 2006: Student debt amongst junior doctors in new Zealand; part 1: quantity, distribution, and psychosocial impact New Zealand Medical Journal 119(1229): U1853
McCoy, K.L.; Kendrick, L.; Chused, T.M. 1986: Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice Journal of Immunology 136(4): 1217-1222
Vaughan, W.J. 2004: Hazardous-materials antidotes Emergency Medical Services 33(4): 71-73
Trouvé, R.; Nahas, G.G. 1990: Antidotes to lethal cocaine toxicity in the rat Archives Internationales de Pharmacodynamie et de Therapie 305: 197-207
Endo, Y. 2007: Problems over provision of antidotes in Japan Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi 20(1): 13-18
Schep, L.J.; Slaughter, R.J.; Temple, W.A. 2011: Synthetic cannabinoid use in New Zealand: a brief evaluation of inquiries to the New Zealand National Poisons Centre New Zealand Medical Journal 124(1347): 99-101
Garrett, J.; Chen, B.; Taylor, D.Robin. 2009: A survey of respiratory and sleep services in New Zealand undertaken by the Thoracic Society of Australia and New Zealand (TSANZ) New Zealand medical journal 122(1289): 10-23
Berndt, E. 1994: Posted list of emergency drugs and antidotes American Journal of Hospital Pharmacy 51(20): 2602
Rigby, R.J.; Rozzo, S.J.; Boyle, J.J.; Lewis, M.; Kotzin, B.L.; Vyse, T.J. 2004: New loci from New Zealand Black and New Zealand White mice on chromosomes 4 and 12 contribute to lupus-like disease in the context of BALB/c Journal of Immunology 172(7): 4609-4617
Barnett, J.R. 1991: Where have all the doctors gone? Changes in the geographic distribution of general practitioners in New Zealand since 1975 (3): New Zealand and foreign medical graduates compared New Zealand Medical Journal 104(918): 358-360
Conde, C.; Weller, S.; Gilfillan, S.; Marcellin, L.; Martin, T.; Pasquali, J.L. 1998: Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice Journal of Immunology 161(12): 7023-7030
Wesley, A.W.; Asher, M.I.; Gillies, J.D.; Pattemore, P.K.; Kerr, A.; Hewitt, C. 1996: Proposals for standards of cystic fibrosis management in New Zealand. A position statement by the Respiratory Committee of the Paediatric Society of New Zealand New Zealand Medical Journal 109(1020): 140-141
Trouvé, R.; Nahas, G. 1988: A technic for selection of antidotes to an acute lethal poisoning Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 182(4): 421-424
Jones, S.G.; Basinger, M.A.; Jones, M.M.; Gibbs, S.J. 1982: A comparison of diethyldithiocarbamate and EDTA as antidotes for acute cadmium intoxication Research Communications in Chemical Pathology and Pharmacology 38(2): 271-278
Stozek, T.; Krówczyński, L.; Bohdanowicz, T. 1983: Comparative studies on drug release from tablets in vitro and its biological availability. II. Biological availability of sodium salicylate from tablets of various formulations Acta Poloniae Pharmaceutica 40(1): 77-87
Daunderer, M. 1980: Therapy in poisonings--antidote 7: the antidotes physostigmine salicylate, toluidin blue Fortschritte der Medizin 98(7): 245-248
Clarkson, T.W.; Magos, L.; Cox, C.; Greenwood, M.R.; Amin-Zaki, L.; Majeed, M.A.; Al-Damluji, S.F. 1981: Tests of efficacy of antidotes for removal of methylmercury in human poisoning during the Iraq outbreak Journal of Pharmacology and Experimental Therapeutics 218(1): 74-83